Specific Immune-Related Renal Diseases: IgA Nephropathy

 IgA Nephropathy 

IgA nephropathy or Berger’s disease is the most common cause of glomerulonephritis in the world. Rarely seen in blacks, this dis-ease afflicts mainly Asians and Caucasians. Clinical features include gross hematuria (40–50 percent), microscopic hematuria (30–40 percent), and rarely, renal insuffi-ciency with edema and hypertension (less than 10 percent). These usually occur after a respiratory infection. Minimal protein-uria is noted. IgA nephropathy is made by kidney biopsy only. The hallmark of this disease is mesangial deposition of IgA, which is prominently noted on immuno-fluorescence. This deposition is associated with focal mesangial expansion, which can be seen on light microscopy. Electron microscopy confirms the presence of elec-tron-dense deposits in the mesangium, which correspond to the immune complex deposits. An abnormality in the regula-tion of IgA may exist because of an envi-ronmental stimuli. This is supported by higher circulating levels of IgA in about 50 percent of cases, circulating immune com-plexes that parallel the duration of the dis-ease, and increased number of IgA-specific B and T lymphocytes. Its strong association with respiratory infection has led authori-ties to believe that mucosal immunity plays a role in this disease. Exaggerated muco-sal IgA response or decreased clearance may explain the elevated levels of plasma IgA in this disease. In the glomeruli, IgA-containing immune complexes activate the alternative complement pathway but do not bind C1, which may slow the removal of circulating complexes and thereby pro-mote deposition in the glomeruli.

The role of fibronectin and uteroglobin (an anti-inflammatory protein) in IgA nephropathy remains unclear. Most of the IgA-containing complexes are bound to fibronectin. In experimental animals, uteroglobin–fibronectin heteromerization prevented formation of fibronectin–IgA complexes and binding to glomeruli. Dele-tion of the uteroglobin gene in mice by gene knockout or suppression of the uteroglobin gene by antisense technology has histolog-ical features similar to IgA nephropathy. Interestingly, polymeric but not monomeric IgA binds only to mesangial cells, which stimulate release of IL-6, further leading to mesangial expansion.

 

IgA nephropathy usually follows a benign course, although about 15 per-cent of cases may reach end-stage renal disease at ten years and 20 percent at twenty years. Clinical and histopatho-logical predictors of progression of renal disease include worsening proteinuria (>1 g/day of proteinuria) and biopsy findings of glomerular sclerosis, tubular atrophy, interstitial fibrosis, and crescent forma-tion. Treatment of IgA nephropathy has radically changed over the past decade. Aggressive use of angiotensin-converting enzyme (ACE) with and without angio-tensin-receptor blocker (ARB) is recom-mended to decrease the proteinuria and for their renoprotective properties. Cyto-toxic agents and steroids are reserved for aggressive renal disease.

Comments

Popular posts from this blog

Hematopoietic Stem Cell Transplantation

Basic Components of the Immune System

Etiologic Considerations of Rheumatic Fever